Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Orum Therapeutics, Inc.
No Price
Closing Price XKOS 29.04.2026:
89.500,00 KRW
29.04.2026 06:30
Current Prices from Orum Therapeutics, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
KOSDAQ
475830.KQ
KRW
29.04.2026 06:30
89.500,00 KRW
-2.000,00 KRW
-2,19 %
Share Float & Liquidity
Free Float71,78 %
Shares Float15,19 M
Shares Outstanding21,16 M
Company Profile for Orum Therapeutics, Inc. Share
Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases. The company focuses on degrader-antibody conjugate that combine antibody-drug conjugate with targeted protein degradation technology. Its lead product candidate is ORM-1153, a GSPT1 protein degrader that targets hematologic malignancies. The company was founded in 2016 and is based in Daejeon, South Korea.
